FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy
STAT   20 hours ago
ads
Read Full Story
FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy  STATCapricor shares sink as US FDA declines to approve cell therapy  ReutersFDA rejects approval of Capricor's cell therapy for DMD  FirstWord PharmaCapricor Shares Sink After FDA...